Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: A substudy of the ATADAR randomized study

Maria Saumoy, Jordi Ordóñez-Llanos, Esteban Martínez, Elena Ferrer, Pere Domingo, Esteban Ribera, Eugenia Negredo, Jordi Curto, José Luis Sánchez-Quesada, Silvana Di Yacovo, Ana Gonzá Lez-Cordón, Daniel Podzamczer

Research output: Contribution to journalArticleResearchpeer-review

12 Citations (Scopus)

Fingerprint Dive into the research topics of 'Atherogenic properties of lipoproteins in HIV patients starting atazanavir/ritonavir or darunavir/ritonavir: A substudy of the ATADAR randomized study'. Together they form a unique fingerprint.

Medicine & Life Sciences